Beyond AirXAIR
Market Cap: 29.2M
About: Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Employees: 107
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
100% more funds holding in top 10
Funds holding in top 10: 0 [Q4 2023] → 1 (+1) [Q1 2024]
38% more capital invested
Capital invested by funds: $21.2M [Q4 2023] → $29.2M (+$8.01M) [Q1 2024]
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
22% more call options, than puts
Call options by funds: $107K | Put options by funds: $88K
12.76% more ownership
Funds ownership: 33.83% [Q4 2023] → 46.59% (+12.76%) [Q1 2024]
3% more funds holding
Funds holding: 64 [Q4 2023] → 66 (+2) [Q1 2024]
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
Research analyst outlook
2 Wall Street Analysts provided 1 year price forecasts over the past 6 months
2 analyst ratings
Piper Sandler Jason Bednar | 451%upside $3.5 | Overweight Maintained | 25 Jun 2024 |
Truist Securities Gregory Fraser | 1,160%upside $8 | Buy Maintained | 30 Apr 2024 |
Financial journalist opinion
Based on 5 articles about XAIR published over the past 30 days